查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1863134

全球血压监测设备市场：洞察、竞争格局及市场预测（至2032年）

Blood Pressure Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

血压监测设备市场摘要

  • 全球血压监测设备市场预计将从 2024 年的 28.4232 亿美元成长到 2032 年的 60.865 亿美元，反映出强劲且持续的成长。
  • 全球血压监测设备市场在 2025 年至 2032 年的预测期内将以 10.01% 的复合年增长率成长。
  • 血压监测设备市场的主要驱动因素是高血压和心血管疾病的盛行率不断上升、居家医疗和远端患者监护的日益普及、设备技术的不断进步以及参与企业产品开发活动的增加。
  • 在血压监测设备市场营运的主要企业包括：英国皇家飞利浦公司、通用电气公司、A&D公司、Hill-Rom Services Inc.、美国诊断公司、Withings、Spacelabs Healthcare、Braun Healthcare、GF HEALTH PRODUCTS INC、Microlife Corporation、Rossmax International Ltd、欧姆龙医疗保健公司、S.ILL SA和Caretaker LLC。
  • 由于高血压和心血管疾病的高发生率、先进的数位和穿戴式监测技术的广泛应用，以及主要市场参与企业在该地区的存在，预计北美将主导血压监测设备市场。此外，不断增长的医疗保健支出、完善的医疗保健基础设施以及人们对预防保健和家庭监测意识的提高，进一步巩固了北美的市场领先地位。
  • 在血压监测设备市场中，预计到 2024 年，数位/自动血压计中的上臂式血压计将占据主导地位。

血压监测设备市场成长要素

  • 高血压和心血管疾病盛行率的上升推动了血压监测设备的需求激增：高血压和心血管疾病盛行率的上升显着增加了对血压监测设备的需求，因为定期监测对于早期发现、有效管理和预防心臟病发作和中风等併发症至关重要。日益加重的疾病负担促使医疗服务提供者和患者都开始采用先进的监测解决方案，包括家用和穿戴式装置。
  • 居家医疗和远端患者监护的日益普及推动血压监测设备市场成长：随着病患寻求在临床环境之外获得便利、经济且持续的血压监测解决方案，居家医疗和远端患者监护普及正在推动血压监测设备市场的成长。此外，能够与医疗服务提供者即时共用数据的数位化互联设备的兴起也进一步促进了这一趋势。
  • 血压监测设备技术的不断进步：血压监测设备的技术不断进步，包括数位式、穿戴式和人工智慧整合式监测仪的开发，正在提高其准确性、易用性和连接性。这些创新透过实现即时追踪、远端监测以及与医疗保健系统的无缝数据集成，推动了血压监测设备的普及应用。

血压监测设备市场报告细分

本研究报告全面概​​述了全球血压监测设备市场，重点分析了关键趋势、成长驱动因素、挑战和机会。报告按产品、最终用户和地区进行了详细的市场细分，并深入剖析了北美、欧洲和亚太等主要市场的竞争格局、监管环境和市场动态。报告详细介绍了行业领导者的概况和最新的产品创新，为企业提供了识别市场潜力、制定策略规划以及把握快速成长的血压监测设备市场新机会所需的重要数据。

血压监测仪是医疗设备，通常由袖带、感测器和显示器组成。它有助于诊断和管理高血压及相关心血管疾病，并有手动、数位和可穿戴等多种形式，可用于临床和家庭使用。

高血压和心血管疾病盛行率的上升，以及居家医疗和远端患者监护的日益普及，显着推动了血压监测设备的需求。同时，数位和穿戴式监测仪等技术的不断进步，以及主要企业活性化产品研发力度，使得血压监测设备更加精准、易用且普及。这些因素正在加速血压监测设备的普及，并推动整个市场的成长。

血压监测设备市场的最新动态和趋势是什么？

由于高血压和心血管疾病的增加，血压监测设备市场目前正经历快速成长。

根据DelveInsight的预测（2024年），全球30至79岁的成年人中将有约12.9亿人患有高血压。高血压是世界上最常见的慢性疾病之一，需要定期监测才能有效控制，这使其成为推动血压监测设备市场整体成长的主要因素。由于数百万人面临中风、心臟病发作和肾衰竭等严重併发症的风险，持续血压监测的需求正在迅速增长。不断增长的患者群体正在推动家用数位血压计、穿戴式装置和先进的医院血压监测系统的普及，从而促进市场扩张。

此外，根据我们DelveInsight的预测（2024年），2023年七大经济体将新增约2,600万例动脉粥状硬化性心血管疾病病例，预计到2034年这一数字还将进一步成长。心臟病患者需要频繁且准确的监测，以控制风险并预防併发症。由于血压控制不佳是心臟病发作、中风和心臟衰竭的主要原因，医疗保健机构重视在临床环境和家庭环境中定期监测血压，从而推动了血压监测设备市场的整体成长。

此外，主要市场参与企业加强产品研发力度，进一步推动了血压监测设备的整体市场成长。例如，欧姆龙医疗保健公司于2025年5月发布了一款内建人工智慧心房颤动检测功能的家用血压计。血压计是医疗设备的首创，它搭载了欧姆龙公司最新的机器学习演算法IntelliSense™ AFib，可在每次测量血压时自动检测房颤，从而及早发现中风和心臟衰竭的高风险人群。

儘管血压监测设备市场成长强劲，但仍面临许多重大限制与挑战。其中一个关键问题是许多设备（尤其是消费级产品）的准确性和可靠性参差不齐，这损害了患者和医疗专业人员的信任。另一个重大障碍是新设备监管和认证流程严格、耗时且成本高昂，导致产品上市延迟，阻碍创新。此外，经临床验证的先进检验价格昂贵，限制了其普及，尤其是在开发中国家和无健保患者群体中。最后，患者操作失误仍然是一个重大挑战，因为不正确的操作方法和缺乏使用者教育会导致读数不准确，从而降低家庭监测在有效控制高血压方面的价值。

血压监测设备市场細項分析

血压监测设备市场按产品、最终用户和地区划分

上臂式电子/自动血压计市场占主导地位

在血压监测设备市场中，臂式数位/自动血压计预计将占据主导地位，到 2024 年将占市场份额的近 60%。这一领先地位将由几个关键因素驱动。

上臂式血压计被公认为家用血压监测的黄金标准。由于其配戴位置更靠近心臟，上臂式血压计比腕式或指式血压计提供更稳定、更可靠的读数，后者更容易受到位置变化的影响。这种更高的准确性对于有效的病患管理至关重要，也是医疗专业人员始终建议使用上臂式血压计的主要原因。

此外，许多臂式血压计都经过了美国心臟协会 (AHA) 和欧洲高血压学会 (ESH) 等机构制定的临床检验通讯协定的检验。这种检验不仅增强了消费者的信任，也巩固了它们作为临床医生和消费者首选产品的地位。

此外，上臂式血压计正日益整合到远端医疗和远端患者监护（RPM）平台中，从而实现与医疗服务提供者之间的无缝资料共用。其久经考验的可靠性确保医生能够获得准确、可操作的数据，以指南治疗决策，使这些设备成为现代高血压管理的重要组成部分。

按最终用户划分：医院占据市场主导地位

目前，医院产业在血压监测设备市场占据主导地位，预计到2024年将占据超过59%的市场。这一主导地位源自于医院庞大的病患数量、重症加护环境下对持续、高精度监测的需求，以及医院在昂贵的临床级设备上的巨额投入。然而，居家医疗领域正经历着最快的成长。这一趋势的驱动因素包括高血压等慢性疾病在全球范围内的日益普遍、远距远端医疗和远端患者监护（RPM）平台的日益普及，以及以患者为中心的居家医疗的重大转变。老年人口的成长也推动了这一成长，因为家庭监测为长期健康管理提供了一种便利且经济高效的解决方案。

血压监测设备市场区域分析

北美血压监测设备市场趋势

参与企业。此外，医疗保健支出的成长、完善的医疗基础设施以及人们对预防保健和家庭监测意识的提高，进一步巩固了北美的市场领先地位。

DelveInsight 估计（2024 年），到 2023 年，美国将有约 1,400 万名男性和约 11,000 名女性患有动脉粥状硬化性心血管疾病。

此外，分析师预测（2024年），美国超过一半的成年人将患有高血压（48.2%，即1.199亿人）。美国粥状硬化性心血管疾病的高发生率以及高血压患者人数众多，显着扩大了血压监测设备的市场。由于数百万患者面临严重併发症的风险，因此在诊所和家中定期、准确地监测血压的需求日益增长。这种需求正在推动先进的、数位连接的血压监测设备的广泛应用，这些设备支援早期发现、持续管理和改善患者预后。

此外，全部区域不断增加的产品研发活动也进一步推动了血压监测设备的整体市场成长。例如，2024年2月，Joytech Healthcare的全自动臂式电子血压计获得了FDA 510(k)认证。

因此，上述因素预计将推动北美血压监测设备市场的成长。

欧洲血压监测设备市场趋势

欧洲血压监测设备市场的特点是注重品质、人口快速老化以及对综合数位健康解决方案的追求，这使得该地区成为传统和智慧监测技术的关键市场。

欧洲市场的主要趋势

1. 人口老化与慢性病管理：欧洲正经历快速的人口老化，65岁以上人口年龄层高。随着老龄化的增长，高血压和其他心血管疾病的盛行率也随之增加，因此，这种人口结构变化是市场的主要驱动因素。这一趋势推动了对可靠且易于使用的血压监测仪的需求，以便在家中进行长期慢性病管理。

2. 数位/自动血压计的主导地位：虽然传统血压计仍在继续使用，但市场主要由数位/自动血压计，尤其是上臂式血压计。这些设备因其临床准确性和易用性而广受欢迎，这对患者和医护人员来说都是重要的考量。英国和德国是关键市场，这两个国家对高品质、精密设计的血压计需求旺盛。

3.居家医疗领域的成长：欧洲在居家医疗转型方面处于领先地位。 「居家医院」计画以及政府对远端医疗和数位健康的扶持，正在加速远端血压监测仪等设备的应用。这一趋势的驱动力源于对经济高效的医疗保健服务的需求，以及患者越来越偏好在家中舒适地管理自身健康状况。

4. 智慧型装置和远端医疗的兴起：具备蓝牙连接和应用程式整合功能的「智慧型」血压计仪是成长最快的类别。这反映出市场对能够与智慧型手机、平板电脑和远端医疗平台无缝共用数据的设备的需求日益增长，使医生能够远端追踪患者数据，并提供更及时、更个人化的医疗服务。

5. 监管环境（欧盟医疗器材法规）：欧洲市场深受欧盟医疗设备法规 (EU MDR) 的影响。虽然这给一些製造商在合规和认证方面带来了挑战，但也确保了上市医疗器材的高安全性和高性能标准。这种严格的监管有助于建立信任，并巩固欧洲在高品质医疗设备领域的声誉。

亚太地区血压监测设备市场趋势

亚太地区血压监测设备市场正经历显着成长，这得益于人口结构变化、技术普及和医疗保健模式演变的独特组合，使该地区有望在未来几年成为全球成长最快的市场之一。

亚太市场的主要趋势

  • 老年人口的爆炸性成长：亚太地区拥有世界上一些老化速度最快的地区（例如日本、中国和韩国），是市场扩张的主要动力。高血压是该地区老年人口的主要健康问题，庞大的老年人口群体对临床和家用血压监测解决方案的需求也随之激增。
  • 高血压和文明病盛行率上升：在中国和印度等国家，都市化和生活方式的改变导致高血压、肥胖和糖尿病等慢性疾病激增。日益加重的疾病负担，以及人们对定期监测血压必要性的认识不断提高，正在推动血压计的广泛应用。
  • 转向居家医疗和自我监测：医疗保健正呈现出从医院转移到家庭的明显趋势，这主要受对成本效益和患者便利性的需求所驱动。因此，居家医疗产业蓬勃发展，越来越多的消费者购买用于自我监测的数位化和自动化设备。
  • 技术融合：亚太市场是技术创新的温床。
  • 数位和智慧型装置：数位血压计越来越受欢迎，像欧姆龙（日本一家主要企业）这样的公司正在连网设备领域处于主导。
  • 穿戴式科技：虽然目前仍是一个小众市场，但对智慧型手錶和其他可追踪血压的穿戴装置的需求正在成长，尤其是在更年轻、更懂科技、更注重健康的人群中。
  • 远端医疗和人工智慧：政府措施和私人公司正在加速将血压监测仪整合到远端医疗平台和人工智慧驱动的数据分析中，从而实现远端患者监测，改善患者治疗效果和治疗依从性，尤其是在农村人口众多且分散的国家。
  • 政府措施与医疗保健支出成长：该地区许多国家的政府都在积极投资医疗保健基础设施，并实施公共卫生计画以应对慢性疾病，包括向高风险族群分发血压监测仪和进行公众意识提升宣传活动。这种自上而下的支持，加上可支配收入的成长，正在扩大监测设备的普及率和需求。

血压监测设备市场的主要企业

以下列出了血压监测设备市场的主要企业，它们总合占据最大的市场份额，并引领着行业趋势：

  • Koninklijke Philips NV
  • General Electric Company
  • A&D Company
  • Hill-Rom Services Inc.
  • American Diagnostic Corporation
  • Withings
  • Spacelabs Healthcare
  • Braun Healthcare
  • GF HEALTH PRODUCTS INC
  • Microlife Corporation
  • Rossmax International Ltd.
  • OMRON Healthcare Inc.
  • SCHILLER AG
  • Contec, Spengler
  • ICU Medical Inc.
  • B. Braun Melsungen AG
  • Biobeat
  • Aktiia SA
  • Caretaker LLC
  • 其他的

血压监测设备市场集中度适中，少数几家占据主导地位的公司与数量迅速成长的小型创新企业之间形成了明显的竞争格局。欧姆龙、A&D Medical 和飞利浦等传统医疗设备巨头凭藉其成熟的品牌、广泛的分销网络以及对经临床检验的上臂式数位血压计的专注，保持着强大的市场地位。这为新参与企业设定了很高的进入门槛。然而，技术创新的蓬勃发展使市场格局日益活跃。新兴企业和专业公司正在无袖带穿戴装置和人工智慧远端患者监护系统等新兴领域展开激烈竞争。这些新参与企业不仅推出了新产品，还降低了价格，挑战了现有企业的传统经营模式。这种转变迫使市场领导增加研发投入、寻求策略伙伴关係并收购这些小型创新企业，以保持竞争力并拓展其产品系列，进入快速成长的居家医疗和数位健康领域。

血压监测设备市场最新发展动态

  • 2025年1月，FDA核准了Biobeat Technologies Ltd.的BB-613-BPM贴片。 BB-613-BPM贴片是一款穿戴式设备，利用脉搏波传导时间（PWTT）追踪血压变化。本设备需使用FDA核准的示波式血压计进行校准，并提供24小时监测，使用者可每15分钟进行一次测量。收集到的数据可透过Biobeat平台提供给医疗专业人员。
  • 2024年9月，Carematix推出了首款专为临床试验设计的连网盲法血压计和体重计。该系统在确保数据完整性的同时，维持了受试者和临床实验的盲法，从而提高了研究的准确性，并能够在不影响研究通讯协定的前提下及时进行干预。
  • 2024 年 2 月，Joytec Healthcare 的全自动臂式数位血压监测仪获得了 FDA 510(k) 许可。
  • 2024 年 1 月，Nanowear 的 SimpleSense-BP 获得了 FDA 510(k) 许可，这是一款由人工智慧驱动的连续无袖带血压计，专为高血压诊断管理而设计。

血压监测设备市场细分

  • 血压监测设备产品的暴露
  • 数位/自动血压计
  • 穿戴式血压计
  • 上臂血压计
  • 腕式血压计
  • 指式血压计
  • 手动血压计
  • 水银血压计
  • 表式血压计
  • 血压监测设备最终用户暴露
  • 医院
  • 门诊手术中心
  • 居家医疗
  • 其他的
  • 各地区血压监测设备使用量
  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太其他地区
  • 世界其他地区
  • 南美洲
  • 中东
  • 非洲

影响分析

人工智慧驱动的创新与应用：

人工智慧 (AI) 驱动的创新正在革新血压监测设备，实现更精准、个人化和持续的健康评估。 AI 演算法分析复杂的生理讯号，包括脉搏波形、光电容积脉搏波描记法 (PPG) 和心电图 (ECG)，无需依赖传统袖带即可估算血压。这些技术能够进行预测分析、早期发现高血压，并对异常值发出即时警报，使患者和医疗服务提供者都能及时采取干预措施。此外，AI 与穿戴式装置和远端医疗平台的集成，促进了远端监测、数据主导的洞察分析和个人化治疗方案的製定，从而将血压管理从被动应对转变为主动、持续的健康管理。

美国关税对血压监测设备市场的影响分析

美国对进口商品加征的新关税为全球血压监测设备市场带来了重大而复杂的挑战。这些关税提高了关键电子元件的成本，直接增加了製造商的生产成本。这迫使企业要么自行承担这些成本，降低利润率，要么将其转嫁给消费者和医疗服务提供者，从而可能导致家用和临床设备的价格上涨。为了应对这项挑战，企业正在策略性地重新评估并多元化其全球供应链，以减少对高税收国家的依赖。虽然这可能会促进一些国内生产，但这在成本和物流方面都是一项极具挑战性的任务，对中小企业的影响尤其严重。关税的影响在占据市场主导地位的数位/自动化领域将最为显着，而这些设备价格的下降可能会阻碍远端患者监护计画的发展。

这项分析对客户有何帮助？

  • 成本管理：了解关税环境可以让客户预测成本上涨，并据此调整定价策略，确保盈利。
  • 供应链优化：可以确定替代采购方案，实现供应链多元化，以减少对高关税地区的依赖，并提高韧性。
  • 监管导航：在不断变化的法规环境中，专家指导可协助您保持合规并避免潜在的法律挑战。
  • 策略规划洞察关税的影响使客户能够就製造地、伙伴关係和打入市场策略做出明智的决策。

目录

第一章 血压监测设备市场报告概述

2. 血压监测设备市场执行摘要

  • 市场概览

第三章：血压监测设备市场关键因素分析

  • 血压监测设备市场驱动因素
    • 高血压和心血管疾病盛行率不断上升
    • 家庭医疗保健和远端医疗监测的普及程度日益提高
    • 血压监测设备的技术不断进步
    • 主要市场参与者加大产品研发力度
  • 血压监测设备市场的限制与挑战
    • 对设备准确性和可靠性的担忧
    • 严格的规章制度和认证流程
  • 血压监测设备市场机会
    • 人工智慧技术的应用日益广泛

第四章 影响分析

  • 人工智慧驱动的创新和应用
  • 美国关税的影响分析

第五章 监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第六章：血压监测设备市场：波特五力分析

第七章 血压监测设备市场评估

  • 副产品
  • 最终用户
  • 按地区

第八章 竞争情势

第九章Start-Ups资金筹措与投资趋势

10. 血压监测设备市场中的公司与产品概况

  • Koninklijke Philips NV
  • General Electric Company
  • A&D Company
  • Hill-Rom Services Inc.
  • American Diagnostic Corporation
  • Withings
  • Spacelabs Healthcare
  • Braun Healthcare
  • GF HEALTH PRODUCTS INC
  • Microlife Corporation
  • Rossmax International Ltd.
  • OMRON Healthcare Inc.
  • SCHILLER AG
  • Contec
  • Spengler
  • ICU Medical Inc.
  • B. Braun Melsungen AG
  • Biobeat
  • Aktiia SA, Caretaker LLC
  • Caretaker LLC

第十一章：KOL视角

第十二章计划方法

第十三章：关于 DelveInsight

第十四章 免责声明和联络我们

Product Code: DIMDCL0012

Blood Pressure Monitoring Devices Market Summary

  • The global blood pressure monitoring devices market is expected to increase from USD 2,842.32 million in 2024 to USD 6,086.50 million by 2032, reflecting strong and sustained growth.
  • The global blood pressure monitoring devices market is growing at a CAGR of 10.01% during the forecast period from 2025 to 2032.
  • The market of blood pressure monitoring devices is being primarily driven by the rising prevalence of hypertension and cardiovascular diseases, increasing shift towards home healthcare & remote patient monitoring, increasing technological advancements in devices, and an increase in product development activities among the key market players.
  • The leading companies operating in the blood pressure monitoring devices market include Koninklijke Philips N.V., General Electric Company, A&D Company, Hill-Rom Services Inc., American Diagnostic Corporation, Withings, Spacelabs Healthcare, Braun Healthcare, GF HEALTH PRODUCTS INC, Microlife Corporation, Rossmax International Ltd, OMRON Healthcare Inc, SCHILLER AG, Contec, Spengler, ICU Medical Inc, B. Braun Melsungen AG, Biobeat, Aktiia SA, Caretaker LLC, and others.
  • North America is expected to dominate the overall blood pressure monitoring devices market due to the high prevalence of hypertension and cardiovascular diseases, strong adoption of advanced digital and wearable monitoring technologies, and the presence of leading market players in the region. Additionally, rising healthcare expenditure, well-established healthcare infrastructure, and increasing awareness about preventive care and home-based monitoring further strengthen North America's market leadership.
  • In the blood pressure monitoring devices market, the upper arm-based segment within digital/automated blood pressure monitors is projected to dominate in 2024.

Factors Contributing to the Growth of the Blood Pressure Monitoring Devices Market

  • Rising prevalence of hypertension and cardiovascular diseases leading to a surge in blood pressure monitoring devices: The rising prevalence of hypertension and cardiovascular diseases is driving significant demand for blood pressure monitoring devices, as regular monitoring is essential for early detection, effective management, and prevention of complications such as heart attack and stroke. This growing disease burden is pushing both healthcare providers and patients to adopt advanced monitoring solutions, including home-use and wearable devices.
  • Increasing shift towards home healthcare & remote patient monitoring escalating the market of blood pressure monitoring devices: The increasing shift towards home healthcare and remote patient monitoring is boosting the market for blood pressure monitoring devices, as patients seek convenient, cost-effective, and continuous monitoring solutions outside clinical settings. This trend is further supported by the rise of digital and connected devices that enable real-time data sharing with healthcare providers.
  • Increasing technological advancements in blood pressure monitoring devices: Increasing technological advancements in blood pressure monitoring devices, such as the development of digital, wearable, and AI-integrated monitors, are enhancing accuracy, ease of use, and connectivity. These innovations are driving higher adoption by enabling real-time tracking, remote monitoring, and seamless data integration with healthcare systems.

Blood Pressure Monitoring Devices Market Report Segmentation

This Blood Pressure Monitoring Devices market report offers a comprehensive overview of the global blood pressure monitoring devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product (Digital/Automated Blood Pressure Monitors {Wearable Blood Pressure Monitors, Upper Arm-based Blood Pressure Monitors, Wrist-based Blood Pressure Monitors, and Finger-based Blood Pressure Monitors} and Manual Blood Pressure Monitors {Mercury Blood Pressure Monitors and Aneroid Blood Pressure Monitors}), End-User (Hospitals, Ambulatory Surgical Centers, Home-Care Settings, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing blood pressure monitoring devices market.

A blood pressure monitoring device is a medical instrument used to measure and track a person's blood pressure levels, typically consisting of a cuff, sensor, and display. It helps in diagnosing and managing hypertension and related cardiovascular conditions, available in manual, digital, and wearable forms for clinical and home use.

The rising prevalence of hypertension and cardiovascular diseases, coupled with the growing shift towards home healthcare and remote patient monitoring, is significantly driving demand for blood pressure monitoring devices. Alongside this, continuous technological advancements, such as digital and wearable monitors, and increased product development activities by key players are making devices more accurate, user-friendly, and accessible. Collectively, these factors are accelerating adoption and boosting the overall market growth.

What are the latest Blood Pressure Monitoring Devices Market Dynamics and Trends?

The market for blood pressure monitoring devices is gaining pace at present, owing to the rising cases of hypertension and cardiovascular diseases.

According to DelveInsight's estimates (2024), an estimated 1.29 billion adults aged 30-79 years worldwide had hypertension. Hypertension is a major factor boosting the overall market for blood pressure monitoring devices, as it is one of the most common chronic conditions worldwide and requires regular monitoring for effective management. With millions of people at risk of serious complications like stroke, heart attack, and kidney failure, the need for continuous blood pressure tracking is rising rapidly. This growing patient pool is driving higher adoption of home-use digital monitors, wearable devices, and advanced hospital-based systems, thereby fueling market expansion.

Additionally, as per our DelveInsight estimates (2024), in 2023, 7MM accounted for nearly 26 million cases of atherosclerotic cardiovascular disease, which was further expected to increase by 2034. Patients with heart-related conditions require frequent and accurate monitoring to manage risks and prevent complications. Since uncontrolled blood pressure is a leading cause of heart attacks, strokes, and heart failure, healthcare providers emphasize regular tracking, both in clinical settings and at home, thereby boosting the overall market of blood pressure monitoring devices.

Moreover, the increase in product development activities among the key market players is further boosting the overall market of blood pressure monitoring devices. For instance, in May 2025, OMRON Healthcare introduced home blood pressure monitors with built-in AI-powered detection of atrial fibrillation. In a medical device first, OMRON blood pressure monitors, which feature the company's new novel machine learning IntelliSense(TM) AFib algorithm, will automatically check for AFib during every blood pressure measurement and can provide early detection for a high stroke and heart failure risk.

The blood pressure monitoring devices market faces several significant restraints and challenges despite its robust growth. A primary concern is the inconsistent accuracy and reliability of many devices, especially consumer-grade models, which erodes trust among both patients and healthcare professionals. The stringent regulatory and certification processes for new devices are also a major hurdle, as they can be both time-consuming and costly, thereby delaying product launches and hindering innovation. Furthermore, the high cost of clinically validated and advanced monitors limits their accessibility, particularly in developing economies or for uninsured patients. Lastly, patient user error remains a significant challenge, as improper technique and a lack of user education can lead to inaccurate readings, compromising the value of home monitoring for effective hypertension management.

Blood Pressure Monitoring Devices Market Segment Analysis

Blood Pressure Monitoring Devices Market by Product (Digital/Automated Blood Pressure Monitors {Wearable Blood Pressure Monitors, Upper Arm-based Blood Pressure Monitors, Wrist-based Blood Pressure Monitors, and Finger-based Blood Pressure Monitors} and Manual Blood Pressure Monitors {Mercury Blood Pressure Monitors and Aneroid Blood Pressure Monitors}), End-User (Hospitals, Ambulatory Surgical Centers, Home-Care Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

By Product: Upper Arm-based Digital/Automated Blood Pressure Monitor Category Dominates the Market

In the blood pressure monitoring devices market, the upper arm-based segment within digital/automated blood pressure monitors is projected to dominate in 2024, accounting for nearly 60% of the market share. This leadership is driven by several key factors.

Upper arm monitors are widely regarded as the gold standard for at-home blood pressure measurement. Positioned closer to the heart, they provide more consistent and reliable readings than wrist or finger monitors, which are often influenced by body position. This higher level of accuracy is critical for effective patient management and is a major reason why healthcare professionals consistently recommend them.

Furthermore, many upper arm monitors have undergone clinical validation against protocols established by organizations such as the American Heart Association (AHA) and the European Society of Hypertension (ESH). This validation not only builds trust but also solidifies their position as the preferred choice for both clinicians and consumers.

In addition, upper arm monitors are increasingly being integrated into telehealth and remote patient monitoring (RPM) platforms, enabling seamless data sharing with healthcare providers. Their proven reliability ensures that physicians receive accurate, actionable data to guide treatment decisions, making these devices a cornerstone of modern hypertension management.

By End-User: Hospitals Dominate the Market

In the blood pressure monitoring devices market, the Hospitals segment currently holds the dominant position, with a market share of over 59% in 2024. This dominance is attributed to the high volume of patients they serve, the need for continuous and highly accurate monitoring in critical care settings, and their substantial spending on expensive, clinical-grade devices. However, the Home Healthcare segment is experiencing the most rapid growth. This trend is fueled by the rising global prevalence of chronic diseases like hypertension, the growing acceptance of telehealth and remote patient monitoring (RPM) platforms, and a major shift towards patient-centric, at-home care. The increasing geriatric population also drives this growth, as home-based monitoring provides a convenient and cost-effective solution for long-term health management.

Blood Pressure Monitoring Devices Market Regional Analysis

North America Blood Pressure Monitoring Devices Market Trends

North America is projected to dominate the global blood pressure monitoring devices market in 2024, accounting for approximately 35% of the total share, driven by the high prevalence of hypertension and cardiovascular diseases, strong adoption of advanced digital and wearable monitoring technologies, and the presence of leading market players in the region. Additionally, rising healthcare expenditure, well-established healthcare infrastructure, and increasing awareness about preventive care and home-based monitoring further strengthen North America's market leadership.

According to the DelveInsight estimates (2024), in the United States, in 2023, ~14 million males and ~11 thousand females were affected with Atherosclerotic Cardiovascular Disease.

Additionally, as per our analyst estimates (2024), more than half of adults had high blood pressure (48.2%, 119.9 million) in the United States. The high burden of atherosclerotic cardiovascular disease and the large population affected by hypertension in the United States are significantly boosting the market for blood pressure monitoring devices. With millions of patients at risk of severe complications, there is a growing need for regular and accurate blood pressure monitoring in both clinical and home settings. This demand is driving wider adoption of advanced, digital, and connected devices to support early detection, ongoing management, and better patient outcomes.

Furthermore, the increase in product development activities across the region is further boosting the overall market of blood pressure monitoring devices. For instance, in February 2024, Joytech Healthcare secured FDA 510(k) clearance for its fully automatic, arm-type digital blood pressure monitor.

Therefore, the factors mentioned above are expected to drive the growth of the blood pressure monitoring devices market in North America.

Europe Blood Pressure Monitoring Devices Market Trends

The European blood pressure monitoring devices market is characterized by a strong emphasis on quality, a rapidly aging population, and a push towards integrated digital health solutions. The region is a key market for both traditional and smart monitoring technologies.

Key Trends in the European Market

1. Aging Population and Chronic Disease Management: Europe has a rapidly aging population, with a significant portion of its citizens aged 65 and older. This demographic shift is the primary driver for the market, as the prevalence of hypertension and other cardiovascular diseases increases with age. This trend is fueling demand for reliable, easy-to-use blood pressure monitors for long-term chronic disease management in the home.

2. Dominance of Digital/Automated Monitors: While traditional devices are still in use, the market is overwhelmingly dominated by digital/automated blood pressure monitors, especially the upper-arm-based models. These devices are highly popular due to their clinical accuracy and ease of use, which are critical factors for both patients and healthcare professionals. The UK and Germany, in particular, are leading markets, with a high demand for high-quality, precision-engineered products.

3. Growth of the Home Healthcare Segment: Europe is at the forefront of the shift towards home-based care. "Hospital-at-Home" initiatives and government support for telemedicine and digital health are accelerating the adoption of blood pressure monitors for remote patient monitoring. This trend is driven by the need for cost-effective healthcare delivery and a growing patient preference for managing their conditions from the comfort of their homes.

4. Increasing Adoption of Smart Devices and Telehealth: The "smart" blood pressure monitor segment, which includes devices with Bluetooth connectivity and app integration, is the fastest-growing category. This reflects a growing demand for devices that can seamlessly share data with smartphones, tablets, and telehealth platforms, enabling doctors to remotely track patient data and provide more timely and personalized care.

5. Regulatory Landscape (EU MDR): The European market is heavily influenced by the Medical Devices Regulation (EU MDR). While this has created challenges for some manufacturers in terms of compliance and certification, it also ensures a high standard of safety and performance for devices entering the market. This regulatory rigor builds trust and reinforces Europe's reputation for high-quality medical devices.

Asia-Pacific Blood Pressure Monitoring Devices Market Trends

The Asia-Pacific blood pressure monitoring devices market is experiencing significant growth, driven by a unique blend of demographic shifts, technological adoption, and evolving healthcare models. The region is poised to be one of the fastest-growing markets globally in the coming years.

Key Trends in the Asia-Pacific Market

  • Explosive Growth in the Geriatric Population: The Asia-Pacific region, home to some of the world's most rapidly aging societies (e.g., Japan, China, and South Korea), is a major catalyst for market expansion. Hypertension is a key health concern in this demographic, and the sheer volume of older individuals is creating a massive demand for both clinical and home-based blood pressure monitoring solutions.
  • Rising Prevalence of Hypertension and Lifestyle Diseases: Urbanization and changing lifestyles in countries like China and India have led to a surge in chronic diseases, including hypertension, obesity, and diabetes. This increasing disease burden, coupled with a growing awareness of the need for regular monitoring, is fuelling the adoption of blood pressure monitors.
  • Shift to Home Healthcare and Self-Monitoring: There is a clear trend towards decentralizing healthcare from hospitals to homes. This is driven by the desire for cost-effective care and patient convenience. As a result, the home healthcare segment is growing rapidly, with consumers increasingly purchasing digital and automated devices for self-monitoring.
  • Technological Integration: The Asia-Pacific market is a hotbed for technological innovation.
  • Digital and Smart Devices: The adoption of digital blood pressure monitors is widespread, with companies like OMRON (a major domestic player in Japan) leading the charge with connected devices.
  • Wearable Tech: While still a smaller segment, there is a rising demand for smartwatches and other wearables that can track blood pressure, particularly among the tech-savvy younger population and those with a focus on wellness.
  • Telehealth and AI: Government initiatives and private companies are increasingly integrating blood pressure monitors with telehealth platforms and AI-powered data analytics. This allows for remote patient monitoring, especially in countries with vast and dispersed rural populations, improving patient outcomes and treatment adherence.
  • Government Initiatives and Increased Healthcare Spending: Many governments in the region are actively investing in healthcare infrastructure and implementing public health programs to combat chronic diseases. For example, some programs involve distributing blood pressure monitors to at-risk populations and promoting public awareness campaigns. This top-down support, combined with rising disposable incomes, is expanding access to and demand for monitoring devices.

Who are the major players in the blood pressure monitoring devices market?

The following are the leading companies in the blood pressure monitoring devices market. These companies collectively hold the largest market share and dictate industry trends.

  • Koninklijke Philips N.V.
  • General Electric Company
  • A&D Company
  • Hill-Rom Services Inc.
  • American Diagnostic Corporation
  • Withings
  • Spacelabs Healthcare
  • Braun Healthcare
  • GF HEALTH PRODUCTS INC
  • Microlife Corporation
  • Rossmax International Ltd.
  • OMRON Healthcare Inc.
  • SCHILLER AG
  • Contec, Spengler
  • ICU Medical Inc.
  • B. Braun Melsungen AG
  • Biobeat
  • Aktiia SA
  • Caretaker LLC
  • Others

How is the competitive landscape shaping the blood pressure monitoring devices market?

The blood pressure monitoring devices market is moderately concentrated, with a clear competitive divide between a few dominant players and a rapidly growing segment of smaller, innovative companies. Traditional medical device giants like OMRON, A&D Medical, and Philips maintain a strong hold on the market due to their established brand reputation, extensive distribution networks, and a focus on clinically validated, upper-arm digital monitors. This creates a high barrier to entry for newcomers. However, the landscape is becoming increasingly dynamic due to the surge of technological innovation. Startups and specialized firms are aggressively competing in emerging categories, such as cuffless wearables and AI-powered remote patient monitoring systems. These new players are not only introducing novel products but are also driving down prices and challenging the traditional business models of established companies. This shift has forced market leaders to invest heavily in R&D, pursue strategic partnerships, and acquire these smaller innovators to stay competitive and expand their product portfolios into the fast-growing home healthcare and digital health segments.

Recent Developmental Activities in the Blood Pressure Monitoring Devices Market

  • In January 2025, the FDA cleared Biobeat Technologies Ltd.'s BB-613-BPM Patch, a wearable device that tracks blood pressure changes using Pulse Wave Transit Time (PWTT). This device requires calibration with an FDA-cleared oscillometric monitor and provides 24-hour monitoring with user-initiated measurements every 15 minutes. Data collected can be accessed via the Biobeat platform for healthcare professionals to review.
  • In September 2024, Carematix launched the first connected blinded blood pressure monitor and scale designed for clinical trials. This system ensures data integrity while maintaining participant and investigator blinding, supporting trial accuracy, and enabling timely interventions without compromising study protocols.
  • In February 2024, Joytech Healthcare secured FDA 510(k) clearance for its fully automatic, arm-type digital blood pressure monitor.
  • In January 2024, Nanowear received FDA 510(k) clearance for its SimpleSense-BP-an AI-enabled, continuous, cuffless blood pressure monitor designed for hypertension diagnostic management.

Blood Pressure Monitoring Devices Market Segmentation

  • Blood Pressure Monitoring Devices Product Exposure
  • Digital/Automated Blood Pressure Monitors
  • Wearable Blood Pressure Monitors
  • Upper Arm-based Blood Pressure Monitors
  • Wrist-based Blood Pressure Monitors
  • Finger-based Blood Pressure Monitors
  • Manual Blood Pressure Monitors
  • Mercury Blood Pressure Monitors
  • Aneroid Blood Pressure Monitors
  • Blood Pressure Monitoring Devices End-Users Exposure
  • Hospitals
  • Ambulatory Surgical Centers
  • Home-Care Settings
  • Others
  • Blood Pressure Monitoring Devices Geography Exposure
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Rest of the World
  • South America
  • Middle East
  • Africa

Impact Analysis

AI-Powered Innovations and Applications:

Artificial intelligence (AI)-powered innovations are revolutionizing blood pressure monitoring devices by enabling more accurate, personalized, and continuous health assessments. AI algorithms analyze complex physiological signals, such as pulse waveforms, photoplethysmography (PPG), and electrocardiography (ECG), to estimate blood pressure without relying solely on traditional cuffs. These technologies allow for predictive analytics, early detection of hypertension, and real-time alerts for abnormal readings, empowering both patients and healthcare providers to make timely interventions. Additionally, AI integration with wearable devices and telemedicine platforms facilitates remote monitoring, data-driven insights, and personalized treatment plans, transforming blood pressure management from reactive care to proactive, continuous health management.

U.S. Tariff Impact Analysis on Blood Pressure Monitoring Devices Market:

The new U.S. tariffs on imported goods are a significant and complex headwind for the global blood pressure monitoring devices market. By raising the cost of essential electronic components, these tariffs directly increase production expenses for manufacturers. This forces companies to either absorb the cost, which erodes profit margins, or pass it on to consumers and healthcare providers, potentially leading to higher prices for both home-use and clinical devices. In response to this, companies are strategically re-evaluating and diversifying their global supply chains to reduce reliance on heavily taxed countries. While this may incentivize some domestic production, it is a costly and logistically challenging endeavor that disproportionately affects smaller companies. The tariffs' impact is felt most acutely in the dominant digital/automated segment and could hinder the growth of remote patient monitoring programs by making these devices less affordable.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the blood pressure monitoring devices market report study

  • Market size analysis for the current blood pressure monitoring devices market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the blood pressure monitoring devices market.
  • Various opportunities available for the other competitors in the blood pressure monitoring devices market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current blood pressure monitoring devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the blood pressure monitoring devices market growth in the future?

Frequently Asked Questions for the Blood Pressure Monitoring Devices Market

1. What is the growth rate of the blood pressure monitoring devices market?

  • The blood pressure monitoring devices market is estimated to grow at a CAGR of 10.01% during the forecast period from 2025 to 2032.

2. What is the market for blood pressure monitoring devices?

  • The blood pressure monitoring devices market was valued at USD 2,842.32 million in 2024, and is expected to reach USD 6,086.50 million by 2032.

3. Which region has the highest share in the blood pressure monitoring devices market?

  • North America is expected to dominate the overall blood pressure monitoring devices market due to the high prevalence of hypertension and cardiovascular diseases, strong adoption of advanced digital and wearable monitoring technologies, and the presence of leading market players in the region. Additionally, rising healthcare expenditure, well-established healthcare infrastructure, and increasing awareness about preventive care and home-based monitoring further strengthen North America's market leadership.

4. What are the drivers for the blood pressure monitoring devices market?

  • The rising prevalence of hypertension and cardiovascular diseases, coupled with the growing shift towards home healthcare and remote patient monitoring, is significantly driving demand for blood pressure monitoring devices. Alongside this, continuous technological advancements, such as digital and wearable monitors, and increased product development activities by key players are making devices more accurate, user-friendly, and accessible. Collectively, these factors are accelerating adoption and boosting the overall market growth.

5. Who are the key players operating in the blood pressure monitoring devices market?

  • Some of the key market players operating in the blood pressure monitoring Devices market include Koninklijke Philips N.V., General Electric Company, A&D Company, Hill-Rom Services Inc., American Diagnostic Corporation, Withings, Spacelabs Healthcare, Braun Healthcare, GF HEALTH PRODUCTS INC, Microlife Corporation, Rossmax International Ltd, OMRON Healthcare Inc., SCHILLER AG, Contec, Spengler, ICU Medical Inc., B. Braun Melsungen AG, Biobeat, Aktiia SA, Caretaker LLC, and others.

Table of Contents

1. Blood Pressure Monitoring Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Blood Pressure Monitoring Devices Market Executive Summary

  • 2.1 Market at Glance

3. Blood Pressure Monitoring Devices Market Key Factors Analysis

  • 3.1 Blood Pressure Monitoring Devices Market Drivers
    • 3.1.1 Rising prevalence of hypertension and cardiovascular diseases
    • 3.1.2 Increasing shift towards home healthcare & telehealth monitoring
    • 3.1.3 Increasing technological advancements in blood pressure monitoring devices
    • 3.1.4 Increase in product development activities among the key market players
  • 3.2 Blood Pressure Monitoring Devices Market Restraints and Challenges
    • 3.2.1 Concerns over Device Accuracy and Reliability
    • 3.2.2 Stringent Regulatory and Certification Process
  • 3.3 Blood Pressure Monitoring Devices Market Opportunity
    • 3.3.1 Increasing Adoption of Artificial Intelligence Technology

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Blood Pressure Monitoring Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Blood Pressure Monitoring Devices Market Assessment

  • 7.1 By Product
    • 7.1.1 Digital/Automated Blood Pressure Monitors
      • 7.1.1.1 Wearable Blood Pressure Monitors
      • 7.1.1.2 Upper Arm-based Blood Pressure Monitors
      • 7.1.1.3 Wrist-based Blood Pressure Monitors
      • 7.1.1.4 Finger-based Blood Pressure Monitors
    • 7.1.2 Manual Blood Pressure Monitors
      • 7.1.2.1 Mercury Blood Pressure Monitors
      • 7.1.2.2 Aneroid Blood Pressure Monitors
  • 7.2 By End-Users
    • 7.2.1 Hospitals
    • 7.2.2 Ambulatory Surgical Centers
    • 7.2.3 Home-Care Settings
    • 7.2.4 Others
  • 7.3 By Geography
    • 7.3.1 North America
      • 7.3.1.1 United States Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.1.2 Canada Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.1.3 Mexico Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
    • 7.3.2 Europe
      • 7.3.2.1 France Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.2.2 Germany Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.2.3 United Kingdom Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.2.4 Italy Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.2.5 Spain Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.2.6 Rest of Europe Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
    • 7.3.3 Asia-Pacific
      • 7.3.3.1 China Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.3.2 Japan Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.3.3 India Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.3.4 Australia Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.3.5 South Korea Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.3.6 Rest of Asia-Pacific Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
    • 7.3.4 Rest of the World (RoW)
      • 7.3.4.1 Middle East Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.4.2 Africa Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.4.3 South America Blood Pressure Monitoring Devices Market Size In USD Million (2022-2032)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Blood Pressure Monitoring Devices Market Company and Product Profiles

  • 10.1 Koninklijke Philips N.V.
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 General Electric Company
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 A&D Company
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Hill-Rom Services Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 American Diagnostic Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Withings
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 Spacelabs Healthcare
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Braun Healthcare
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 GF HEALTH PRODUCTS INC
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 Microlife Corporation
    • 10.10.1 Compan Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 Rossmax International Ltd.
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 OMRON Healthcare Inc.
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 SCHILLER AG
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 Contec
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 Spengler
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 ICU Medical Inc.
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 B. Braun Melsungen AG
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 Biobeat
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 Aktiia SA, Caretaker LLC
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 Caretaker LLC
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Blood Pressure Monitoring Devices Market in Global (2022-2032)
  • Table 2: Blood Pressure Monitoring Devices Market in Global by Product (2022-2032)
  • Table 3: Blood Pressure Monitoring Devices Market in Global by End-User (2022-2032)
  • Table 4: Blood Pressure Monitoring Devices Market in Global by Geography (2022-2032)
  • Table 5: Blood Pressure Monitoring Devices Market in North America (2022-2032)
  • Table 6: Blood Pressure Monitoring Devices Market in the United States (2022-2032)
  • Table 7: Blood Pressure Monitoring Devices Market in Canada (2022-2032)
  • Table 8: Blood Pressure Monitoring Devices Market in Mexico (2022-2032)
  • Table 9: Blood Pressure Monitoring Devices Market in Europe (2022-2032)
  • Table 10: Blood Pressure Monitoring Devices Market in France (2022-2032)
  • Table 11: Blood Pressure Monitoring Devices Market in Germany (2022-2032)
  • Table 12: Blood Pressure Monitoring Devices Market in United Kingdom (2022-2032)
  • Table 13: Blood Pressure Monitoring Devices Market in Italy (2022-2032)
  • Table 14: Blood Pressure Monitoring Devices Market in Spain (2022-2032)
  • Table 15: Blood Pressure Monitoring Devices Market in the Rest of Europe (2022-2032)
  • Table 16: Blood Pressure Monitoring Devices Market in Asia-Pacific (2022-2032)
  • Table 17: Blood Pressure Monitoring Devices Market in China (2022-2032)
  • Table 18: Blood Pressure Monitoring Devices Market in Japan (2022-2032)
  • Table 19: Blood Pressure Monitoring Devices Market in India (2022-2032)
  • Table 20: Blood Pressure Monitoring Devices Market in Australia (2022-2032)
  • Table 21: Blood Pressure Monitoring Devices Market in South Korea (2022-2032)
  • Table 22: Blood Pressure Monitoring Devices Market in Rest of Asia-Pacific (2022-2032)
  • Table 23: Blood Pressure Monitoring Devices Market in the Rest of the World (2022-2032)
  • Table 24: Blood Pressure Monitoring Devices Market in the Middle East (2022-2032)
  • Table 25: Blood Pressure Monitoring Devices Market in Africa (2022-2032)
  • Table 26: Blood Pressure Monitoring Devices Market in South America (2022-2032)
  • Table 27: Competitive Landscape
  • Table 28: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Blood Pressure Monitoring Devices Market Drivers
  • Figure 2: Blood Pressure Monitoring Devices Market Restraints
  • Figure 3: Blood Pressure Monitoring Devices Market Opportunities
  • Figure 4: AI-Powered Innovations in the Blood Pressure Monitoring Devices Market
  • Figure 5: US Tariff Impact on Blood Pressure Monitoring Devices Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Blood Pressure Monitoring Devices Market in Global (2022-2032)
  • Figure 10: Blood Pressure Monitoring Devices Market in Global by Product (2022-2032)
  • Figure 11: Blood Pressure Monitoring Devices Market in Global by End-User (2022-2032)
  • Figure 12: Blood Pressure Monitoring Devices Market in Global by Geography (2022-2032)
  • Figure 13: Blood Pressure Monitoring Devices Market in North America (2022-2032)
  • Figure 14: Blood Pressure Monitoring Devices Market in the United States (2022-2032)
  • Figure 15: Blood Pressure Monitoring Devices Market in Canada (2022-2032)
  • Figure 16: Blood Pressure Monitoring Devices Market in Mexico (2022-2032)
  • Figure 17: Blood Pressure Monitoring Devices Market in Europe (2022-2032)
  • Figure 18: Blood Pressure Monitoring Devices Market in France (2022-2032)
  • Figure 19: Blood Pressure Monitoring Devices Market in Germany (2022-2032)
  • Figure 20: Blood Pressure Monitoring Devices Market in United Kingdom (2022-2032)
  • Figure 21: Blood Pressure Monitoring Devices Market in Italy (2022-2032)
  • Figure 22: Blood Pressure Monitoring Devices Market in Spain (2022-2032)
  • Figure 23: Blood Pressure Monitoring Devices Market in the Rest of Europe (2022-2032)
  • Figure 24: Blood Pressure Monitoring Devices Market in Asia-Pacific (2022-2032)
  • Figure 25: Blood Pressure Monitoring Devices Market in China (2022-2032)
  • Figure 26: Blood Pressure Monitoring Devices Market in Japan (2022-2032)
  • Figure 27: Blood Pressure Monitoring Devices Market in India (2022-2032)
  • Figure 28: Blood Pressure Monitoring Devices Market in Australia (2022-2032)
  • Figure 29: Blood Pressure Monitoring Devices Market in South Korea (2022-2032)
  • Figure 30: Blood Pressure Monitoring Devices Market in Rest of Asia-Pacific (2022-2032)
  • Figure 31: Blood Pressure Monitoring Devices Market in the Rest of the World (2022-2032)
  • Figure 32: Blood Pressure Monitoring Devices Market in the Middle East (2022-2032)
  • Figure 33: Blood Pressure Monitoring Devices Market in Africa (2022-2032)
  • Figure 34: Blood Pressure Monitoring Devices Market in South America (2022-2032)
  • Figure 35: Competitive Landscape
  • Figure 36: Startup Funding & Investment Trends